Advanced Bionics v MED-EL Elektromedizinische Geräte Gesellschaft m.b.H. (CoA, ORD_42779/2024, 5 September 2024)
| Date | 5 September 2024 |
|---|---|
| Court | CoA |
| Division | Luxembourg (LU) |
| Type of action | Appeal RoP220.1 |
| Registry reference | APL_24598/2024 · ORD_42779/2024 |
| Parties | Advanced Bionics GmbH, Advanced Bionics Sarl , Advanced Bionics AG v. MED-EL Elektromedizinische Geräte Gesellschaft m.b.H. |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By order of 5 September 2024 (UPC_CoA_207/2024, APL_24598/2024), the Court of Appeal dismissed Advanced Bionics’ appeal against the order of the President of the Court of First Instance of 15 April 2024, which had refused to replace German with English, the language of EP 4 074 373, in the infringement action brought by MED-EL before the Mannheim Local Division. The fact that the parties are based in countries where the claimant’s chosen language is an official language is an important factor (paragraph 12). The order adds that a request to change the language may be made before the statement of defence (paragraph 20).
Question
Did the President misapply Art. 49(5) UPCA by refusing a change to English, when the language of the patent and of the parallel revocation action before the Central Division was English?
Decision
No. The President has a discretion based on fairness and all relevant circumstances, in particular the defendant’s position (paragraph 9), applying the principles set out in Curio Bioscience v 10x Genomics (paragraph 11). The defendants are based in German- or French-speaking countries (paragraph 12), Advanced Bionics is a multinational group with a large patent department, whereas MED-EL, much smaller, has no legal department (paragraph 13). A change would require translations or bilingual proceedings (paragraph 14). The use of English in the technical field does not outweigh where the parties are established (paragraph 16), and MED-EL’s earlier language choices do not by themselves require a change (paragraph 17). The admissibility objection did not need deciding. Rule 323.3 RoP does not prevent the request being made before the statement of defence, and early filing is preferable (paragraphs 19 and 20).
Key points for practice
- The relative size of the parties and whether they have in-house legal resources weigh in the balance under Art. 49(5) UPCA.
- Practical point: defendants should apply for a change of language at the outset, without waiting for the statement of defence.
Provisions applied
- Agreement on a Unified Patent Court
- Art. 49(5)
- Rules of Procedure
- Rules 323 and 323.3
- Case law cited
- Curio Bioscience v 10x Genomics, Court of Appeal, 17 April 2024.
Related decisions
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: UPC Court of Appeal, Supplementary protection certificate (SPC), Biosimilar medicinal product, Launch at risk.
Dhenne Avocats blog: UPC Appeals: What the Numbers Show, Pharmaceutical patents and the UPC: is the Court hostile to them?.
Publications by Matthieu Dhenne: The Launch Letter: How Generics and Biosimilars Should Write to Avoid UPC Urgency (Kluwer Patent Blog).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- defendantMED-EL Elektromedizinische Geräte Gesellschaft m.b.H7 decisions in the corpusFollow this party
- claimantAdvanced Bionics AG7 decisions in the corpusFollow this party
- claimantAdvanced Bionics GmbH5 decisions in the corpusFollow this party
- claimantAdvanced Bionics Sarl5 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Appeal RoP220.1
- Outcome (Dhenne Avocats summary)
- La cour d'appel confirme le maintien de l'allemand : le siège des parties dans des pays germanophones et la disproportion de leurs moyens l'emportent sur l'usage de l'anglais.
- Appeal
- Decision of the Court of Appeal.
- Instance
- Court of Appeal decision.
Patents mentioned
EP 4 074 373mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Curio Bioscience v 10x Genomics (CoA, 17 April 2024) cited in this record
- Advanced Bionics v MED-EL Elektromedizinische Geräte (CFI, 15 April 2024) cited in this record
Patents and standards
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.